Mitochondria as key therapeutic targets for the treatment of corneal fibrosis
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA967702 | ENA |
REPOSITORIES: ENA
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| SRR24448341.fastq.gz | Fastqsanger.gz | |||
| SRR24448342.fastq.gz | Fastqsanger.gz | |||
| SRR24448343.fastq.gz | Fastqsanger.gz | |||
| SRR24448344.fastq.gz | Fastqsanger.gz | |||
| SRR24448345.fastq.gz | Fastqsanger.gz |
Items per page: 5 1 - 5 of 25 |
Similar Datasets
Project description:Over the past decade, our laboratory developed a cat model of corneal wound healing after photorefractive keratectomy (PRK). Recently, we used this model in a combination of in vivo and in vitro approaches to show that myofibroblasts directly inhibit nerve regeneration in the wounded stroma, sub-basal plexus and epithelium. In vitro, two distinct phases to this inhibition have been observed: (1) initial slowing of neurite elongation via a releasable factor, and (2) neurite contact inhibition by myofibroblasts. For phase 1, transforming growth factor beta 1 (TGF-1) was shown to be the soluble, anti-neuritogenic factor released by myofibroblasts, and the specific signaling cascade it triggered to slow neurite elongation was identified. Ultimately, preventing myofibroblast differentiation suppressed both phase 1 and phase 2 inhibition, and resulted in faster nerve regeneration. However, in most cases of accidental injury, patients present after myofibroblast differentiation/fibrosis have occurred. The issue then is no longer preventing fibrosis, but rather overcoming its effects. We recently discovered that the synthetic PPAR ligand and Thiazolidinedione (TZD) drug, Troglitazone, stimulates myofibroblast de-differentiation in vitro and in vivo through a PPAR independent pathway. We now show that this TDZ’s ability to promote myofibroblast de-differentiation can be mimicked by UK-5099, a compound that spares PPAR, instead inhibiting a recently identified alternative target of TZDs: the mitochondrial pyruvate carrier (MPC). The recent literature and our preliminary results thus form a strong premise for refocusing our efforts on mitochondria, and critically testing the hypothesis that inhibiting the MPC facilitates myofibroblast de-differentiation, which together with metabolic remodeling in regenerating nerves can treat both fibrosis and overcome the blocked reinnervation inherent in its context. Work is ongoing to understand the metabolic changes that underlie the ability of TDZs to facilitate wound healing though mito-centric regulation of both myofibroblasts and corneal nerves. Here, we present the results of an RNA sequencing experiment designed to examine changes to the global transcriptome that occur as a result of TGF-β1-induced activation of corneal fibroblasts, and of TDZ- or UK5099-stimulated myofibroblast de-differentiation.
2023-11-02 | GSE231796 | GEO
Project description:Dysregulation of wound healing cascade often results in corneal fibrosis. Increasingly evidence suggest the role of epigentics as one of the regulatory mechanisms that drive corneal fibrosis. The present study investigated epigenetic modulation caused by alkali-induced corneal fibrosis in rabbit model by employing ATAC-Seq to identify transcription factors and gene regulatory elements that drive the disease pathology. We observed a extensive epigenomic reprogramming characterized by reduced chromatin accessibility, promoter-to-enhancer regulatory shifts and selective activation of fibrosis-associated transcriptional networks in the fibrotic corneas. Key known (Sp1, KLF9, NFY, KLF4, and ETV4) and de novo motifs shwoing similarity to KLF17, NRF, and ETV6 were identified that could serve as potential epigenetic tragets for further evaluation as therapeutic approach in treating corneal fibrosis.
2025-08-14 | GSE305524 | GEO
Project description:Corneal endothelial dysfunction is a major cause of global blindness, with an estimated 12.7 million patients awaiting corneal transplantation, and the severe shortage of donor grafts underscores the urgent need for non-surgical therapies. Gene therapy offers a promising alternative, but is hindered by the limitations in existing delivery systems and the scarcity of validated molecular targets capable of reversing core pathophysiology. To address this, we first employed multi-omics analysis and identified FOXO1 as a central and under-explored therapeutic target for corneal endothelial dysfunction. In vivo FOXO1 overexpression effectively improved corneal endothelial function by preserving mitochondria-associated endoplasmic reticulum membrane integrity and mitochondrial Ca²⁺ homeostasis, yet its therapeutic potential was limited by low transfection efficiency. To overcome this, we engineered an AAV-Foxo1 delivery system using a viscous choline chloride-fructose-based deep eutectic solvent (DES) as the carrier. The DES-AAV-Foxo1 delivery system exhibited good biocompatibility, significantly prolonged anterior chamber retention, and enhanced transfection efficiency in corneal endothelial cells compared to conventional AAV delivery. Animal experiments confirmed that it effectively improved corneal endothelial pump activity and mitigates endothelial dysfunction in type 1 diabetes mellitus and Fuchs endothelial corneal dystrophy mouse models. Our findings demonstrated the therapeutic potential of DES-AAV-Foxo1 delivery system for corneal endothelial disorders.
2026-07-15 | GSE325372 | GEO
Project description:Cornea transplantation is a widely performed procedure globally. However, storing donor corneas for extended periods in Optisol-GS storage medium at 4 ℃ can lead to reduced endothelial cell viability, causing severe stromal edema and opacification. This negatively impacts transplantation success. The corneal stroma, crucial for maintaining shape and transparency, was subjected to proteomic analysis after 7- or 14-day preservation. Among 1,545 identified proteins, 1,113 were quantifiable, with 255 significantly regulated in longer preservation. Proteins related to ocular surface immunomodulation decreased, while those involved in extracellular matrix reorganization and fibrosis increased after 14 days. The observed upregulation of extracellular matrix structural proteins and growth factor signaling suggests the occurrence of stromal fibrosis, potentially leading to compromised tissue clarity and vision impairments. This study provides novel insights into the impact of preservation duration on the corneal stroma from a proteomic perspective. Our findings may aid future research in developing long-term preservation techniques and enhancing the quality of preserved corneas, thereby maximizing their clinical usefulness.
| PXD045907 | JPOST Repository
Project description:Dr. Panjwani's laboratory is focusing on the mechanism by which galectins-3 and 7 mediate corneal epithelial cell migration. We are currently performing studies to: (i) identify and characterize the corneal epithelial cell surface and extracellular matrix (ECM) molecules which serve as counterreceptors of galectin-3 and -7, to establish whether the lectins modulate corneal epithelial cell migration by binding to well known integrins, growth factor receptors, and/or ECM molecules and (ii) determine whether galectin-3 mediates corneal epithelial cell migration indirectly by modulating the expression of key adhesion and/or signal transduction molecules by using small interfering RNA, cDNA microarrays and glycogene arrays. We have prepared three independent preparations of total RNA of corneal epithelial cells from WT mice (total six samples) for analysis of glycogene expression. Samples are Normal Cornea (Left eye) and Laser ablation + 16-18 hours healing (right eye)
2010-12-11 | E-GEOD-26009 | biostudies-arrayexpress
Project description:The repair of corneal damage is crucial for maintaining clear vision. When the corneal epithelium is damaged, epithelial cells at the corneal limbus quickly initiate a series of complex biological processes, including cell migration, extracellular matrix remodeling, and cell proliferation and differentiation, to promote repair and wound healing. However, comprehensive studies on the transcriptional heterogeneity of corneal limbal cell populations during migration, proliferation, and differentiation in the context of corneal epithelial injury repair are still lacking. In this study, we conducted a systematic analysis of five major cell types in the corneal limbus, including terminally differentiated cells of corneal epithelium (TDCE), basal cells (BC), transit-amplifying cells (TAC), limbal stem cells (LSC), and conjunctival cells (CC ), using high-throughput long-read single-cell RNA sequencing of corneal limbal tissues from Macaca fascicularis. The corneal epithelium was examined at three time points: before injury (0 days) and after injury (1 day and 3 days). The study focused on the migration, proliferation, and differentiation dynamics of these cells during different stages of corneal injury repair. Additionally, key regulatory genes and their RNA isoforms were investigated to uncover their roles in these processes. The results revealed that LSCs and BCs play pivotal roles in corneal epithelial healing, highlighting the regulatory functions of several key genes and their RNA isoforms in cell migration, proliferation, and differentiation. These include growth factors (e.g., IGF2), extracellular matrix components (e.g., FN1 and LAMC2), integrins (e.g., ITGB1 and ITGAV), and Keratin (e.g., KRT3, KRT12 and KRT6A). The study provides novel insights into the transcriptional landscape at the single-cell level during corneal epithelial damage repair, identifying important cell types and key regulatory genes with corresponding RNA isoforms.
2025-11-01 | GSE278797 | GEO
Project description:Alkali burns cause rapid corneal remodeling, which is characterized by fibrosis, neovascularization, and immune infiltration; however, the cellular dynamics driving these responses remain poorly understood. Here, we present the first single-cell transcriptomic atlas of the rabbit cornea on day 14 postalkali injury, capturing the cellular and molecular architecture of stromal fibrosis. Single-cell RNA sequencing of naïve and injured corneas identified 14 transcriptionally distinct populations, including keratocytes, EMT-like epithelial cells, immune infiltrates, and heterogeneous fibroblast subtypes. Injury induced the expansion of ECM-remodeling fibroblasts and immune cells, accompanied by widespread transcriptional reprogramming. Stromal subclustering revealed four fibroblast states—quiescent, activated, proliferative, and progenitor-like—each with distinct gene signatures and functions. Pseudotime analysis revealed a trajectory from proliferative fibroblasts to ECM-secreting myofibroblasts, marked by stage-specific activation of mitotic, matrix, and contractile programs. Ligand–receptor inference via CellChat identified coordinated signaling through the TGFβ, PDGF, VEGF, and FGF pathways, alongside lesser-known axes such as NAMPT and NECTIN, implicating stromal–vascular crosstalk and metabolic stress in fibrotic progression. This study provides a comprehensive cellular framework for alkali-induced corneal fibrosis and identifies actionable targets for antifibrotic and antiangiogenic intervention in ocular surface disease.
2025-08-07 | GSE302936 | GEO
Project description:ATAC-seq revealing chromatin accessibility and novel motifs linked to corneal fibrosis
| PRJNA1306183 | ENA
Project description: Not available
| S-EPMC12815301 | biostudies-literature
Project description:MicroRNA profile comparison of the corneal endothelium of young and old mice: implications for senescence of the corneal endothelium We collected the corneal endothelia from 30 mice aged 10-13 weeks and the corneal endothelia from 30 mice aged 2 years. The samples were pooled into six groups (y1, y2, y3 and s1, s2, s3). Each group comprised corneal endothelia from ten mice, and these six groups were used for a genome-wide microRNA microarray study.
2013-12-27 | E-GEOD-48094 | biostudies-arrayexpress